Name: microRNA Purification Kit
Brand: Norgen Biotek Corp.
SKU: 21300
Price: 249.000000 USD
Availability: InStock

Features and Benefits

Isolate and extract high quality & quantity miRNA in 30 minutes
Two column kit- eliminate large RNA on the first column and capture microRNA on a second column
Elute microRNA in 25 µL ready for miRNA profiling
Process a wide range of samples- cell, tissue, bacteria, bodily fluids, etc.
Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix

This kit provides a rapid method for the isolation and purification of small RNA molecules (< 200 nt) from cultured animal cells, small tissue samples, bacterial cells, plants, and blood.

Two columns are provided with this kit. The first column captures large RNA, while the small RNA are captured on a second column and are eluted concentrated in 25 µL of nuclease-free water.

The small RNA can be used in various downstream applications relating to miRNA profiling, gene regulation, and functional analysis. The eluted RNA is ready for RT-qPCR, microarrays, and NGS applications.

Background

These small RNAs include regulatory RNA molecules such as microRNA (miRNA) and short interfering RNA (siRNA), as well as tRNA and 5S rRNA. Small RNA molecules are often studied due to their ability to regulate gene expression. miRNAs and siRNAs are typically 20-25 nucleotides long and regulate gene expression by binding to mRNA molecules and affecting their stability or translation.

Details

Supporting Data

Figure 1. High Quality of Isolated RNA with Better Size Exclusion. Small RNA was isolated from HeLa cells using Norgen's microRNA Purification Kit (Lanes C and D) and a competitor's kit (Lanes A and B). Ten microliters of the 50 µL purified small RNA were run on an 8% urea-agarose gel. Lane M is Norgen's 100b RNA ladder. Note that Norgen's kit is isolating only the small (<200 nt) RNA species, with no contaminating larger RNA.

Figure 2. Efficient Removal of Large RNA Species. Different RNA species were isolated from 10⁶ HeLa cells, resolved on an Agilent® Lab-On-A-Chip, and electropherograms were generated. Panel A contains all the RNA species present in 10⁶ HeLa cells as isolated with Norgen's Total RNA Purification Kit and acts as a control. Panel B and C contain RNA that was isolated from 10⁶ HeLa cells using Norgen’s microRNA Purification Kit. One microliter of the 50 µL purified RNA for each fraction was loaded. Panel B shows the large RNA species removed using the Large RNA Removal Columns, and no small RNA can be detected. Panel C shows the small RNA that is isolated using the microRNA Enrichment Columns and shows that there is no contamination of the small RNA with any large RNA species above 200 nt. This demonstrates the effective separation of the small RNA from the large RNA species using Norgen's microRNA Purification Kit.

Figure 3. Effective Small RNA Amplification by End-Point RT-PCR. Norgen's microRNA Purification Kit isolates small RNA that could be amplified in RT-PCR using the poly (A) polymerase extension method. Small RNA was isolated from 1 million HeLa cells, and 10 µL of the 20 µL isolated small RNA were polyadenylated in a 50 µL Poly-(A)-Polymerase reaction. Seven microliters of the polyadenylated RNA were used in a 20 µL reverse transcription reaction with a poly T adaptor primer. One microliter of the reverse transcription was used in a 20 µL PCR reaction with primers against the human microRNAs (miR-21) and 5S rRNA. Panel A shows the amplification of the miR-21 transcript from small RNAs while Panel B shows the 5S rRNA amplification from small RNAs. Lane 1 in both panels shows the results when total RNA isolated from 1 million HeLa cells using Norgen's Total RNA Purification Kit was used as a control. Lanes 2 and 3 contain the successful RT-PCR when the microRNA isolated using Norgen's microRNA Purification Kit was used as the template, and Lanes 4 contain the non-template control. The RT-PCR was successful for both reactions using the microRNA as the template. All PCR products were resolved on a 1X TAE, 3% agarose gel using Norgen's PCR Ranger as the molecular weight ladder.

Figure 4. Better Recovery of miRNAs by Norgen's microRNA Purification Kit. Norgen's microRNA Purification Kit recovers microRNA more effectively than its competitors. Small RNA was isolated from 0.75 million HeLa cells using Norgen's microRNA Purification Kit and a competitors' kits. Relative expression of (A) miR-21, (B) miR-19, and (C) 5S rRNA was determined by RT-qPCR of polyadenylated total RNA samples. RT-qPCR was performed according to Shi and Chiang (2005). Fifteen microliters of the 50 µL isolated RNA were polyadenylated in a 50 µL Poly-(A)-Polymerase reaction. Four microliters of the polyadenylated RNA were used in a 20 µL reverse transcription reaction with a poly T adaptor primer. One microliter of the reverse transcription was then used in a 20 µL qPCR reaction with primers against the human microRNAs (miR-19 and miR-21) and house-keeping small RNA (5S rRNA). The resulting threshold cycle (Ct) values were summarized in the graph. Blue = Norgen's microRNA Purification Kit; orange = Silica-based Competitor micro-RNA Kit; green = Silica-based Competitor Total RNA Kit; red = Phenol-based reagent protocol; yellow = No Template Control. Norgen's microRNA Purification Kit recovered more miRNAs (lower Ct) than the competitor's microRNA-specific Kit.

Kit Specifications
Maximum Column Binding Capacity	Up to 50 μg RNA
Maximum Column Loading Volume	650 μL
Minimum Elution Volume	20 μL
Size of RNA Purified	All sizes, including small RNA < 200 nt
Time to Complete 10 Purifications	25 minutes
Maximum Amount of Starting Material: Animal Cells Animal Tissues Bacteria Plant Tissues Blood	3 x 10⁶ cells 5-25 mg 1 x 10⁹ cells 50 mg 100 μL

Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. This kit is stable for 1 year after the date of shipment.

Component	Cat. 21300 (25 preps)
Buffer RL	40 mL
Wash Solution A	38 mL
Elution Solution A	6 mL
Large RNA Removal Column	25
microRNA Enrichment Column	25
Collection Tube	50
Elution Tubes (1.7 mL)	50
Product Insert	1

Documentation

FLYERS

Flyer

RELATED BLOGS

FAQs

Why do I have poor RNA recovery?

Poor RNA recovery could be due to one or more of the following:

Incomplete lysis of cells or tissue. Ensure that the appropriate amount of Buffer RL was used for the amount of cells or tissue.
Large RNA Removal Column has become clogged. Do not exceed the recommended amounts of starting materials. The amount of starting material may need to be decreased if the column shows clogging below the recommended levels. See FAQ related to “Clogged Column” below.
An alternative elution solution was used. It is recommended that the Elution Solution A supplied with this kit be used for maximum RNA recovery.
Low RNA content. Different tissues and cells have different RNA contents. Some tissues may not contain small RNA at detectable levels when processing the small sample sizes required for this procedure.
Flowthrough from the first binding step was discarded. The flowthrough from the binding step with the Large RNA Removal Column contains the small RNA molecules, thus ensure that it is not inadvertently discarded.
Ethanol was not added to the flowthrough before binding to the microRNA Enrichment Column. Ensure that the appropriate amount of ethanol was added to the flowthrough from the first binding step before it is applied to the microRNA Enrichment Column. This is imperative in order to capture the small RNA molecules.
Ethanol was not added to the Wash Solution A. Ensure that 90 mL of 96 – 100% ethanol is added to the supplied Wash Solution A prior to use.
Cell Culture: Cell monolayer was not washed with PBS. Ensure that the cell monolayer is washed with the appropriate amount of PBS in order to remove residual media from cells.
Bacteria: All traces of media not removed. Ensure that all media is removed prior to the addition of the Buffer RL through aspiration.

I noticed the columns are clogged. What causes this?

Column clogging can result from one or a combination of the following factors:

Insufficient solubilization of cells or tissues. Ensure that the appropriate amount of Lysis Buffer was used for the amount of cells or tissue.
Maximum number of cells or amount of tissue exceeds kit specifications. Refer to specifications to determine if the amount of starting material falls within kit specifications.
High amounts of genomic DNA present in sample. The lysate may be passed through a 25 gauge needle attached to a syringe 5-10 times in order to shear the genomic DNA prior to loading onto the Large RNA Removal Column.
Centrifuge temperature is too low. Ensure that the centrifuge remains at room temperature throughout the procedure. Temperatures below 15°C may cause precipitates to form that can cause the columns to clog.

Why is the RNA degraded?

RNA can be degraded due to the following factors:

RNase contamination. RNases may be introduced during the use of the kit. Ensure proper procedures are followed when working with RNA. Please refer to “Working with RNA” at the beginning of this user guide.
Procedure not performed quickly enough. In order to maintain the integrity of the RNA, it is important that the procedure be performed quickly. This is especially important for the Cell Lysate Preparation Step in the Animal Tissue protocol, since the RNA in animal tissues is not protected after harvesting until it is disrupted and homogenized.
Improper storage of the purified RNA. For short term storage, RNA samples may be stored at –20°C for a few days. It is recommended that samples be stored at –70°C for longer term storage.
Frozen tissues or pellets were allowed to thaw prior to disruption. Tissue samples should be flash-frozen in liquid nitrogen and transferred immediately to a -70°C freezer for long term storage. Do not allow frozen tissues to thaw prior to grinding with the mortar and pestle in order to ensure that the integrity of the RNA is not compromised.

Why is the RNA not performing well in downstream applications?

If the RNA does not perform well in downstream applications, it may be due to one or more of the following:

RNA was not washed 3 times with the provided Wash Solution A. Traces of salt from the binding step may remain in the sample if the well is not washed 3 times with Wash Solution A. Salt may interfere with downstream applications, and thus must be washed from the well.
Ethanol carryover. Ensure that the dry spin under Column Wash in the centrifugation protocol or the extended vacuum in the vacuum protocol is performed in order to remove traces of ethanol prior to elution. Ethanol is known to interfere with many downstream applications.

I noticed genomic DNA contamination. How to prevent/correct this?

The contamination with genomic DNA may be due to large amount of starting material used. Perform RNase-free DNase I digestion on the RNA sample after elution to remove genomic DNA contamination. It is recommended that Norgen’s RNase-Free DNase I Kit (Product # 25710) be used for this step.

Why is there large RNA species present in the elution?

Large RNA species may be present in the elution due to:

Improper amount of ethanol added to the lysate before binding to the Large RNA Removal Column. Ensure that the appropriate amount of ethanol was added to the lysate before it is applied to the Large RNA Removal Column. This is imperative in order to capture the large RNA molecules onto the column.
Large amount of starting material used. Repeat purification using less starting material. Alternatively, the isolation procedure can be repeated using the elution as the input. The elution volume should first be adjusted to 300 µL using the provided Buffer RL. The procedure can then be followed as written in the manual, starting with the addition of ethanol, centrifuging the lysate in order to pellet any debris, and applying the clarified lysate to the Large RNA Removal Column. Repeating the procedure should result in the removal of the large, contaminating RNA species.

Is it possible to purify microRNA from frozen blood samples?

Although it is recommended to use fresh non-coagulating (EDTA) blood for RNA purification, frozen blood samples can also be processed. Please thaw the frozen blood samples on ice for 15 minutes, and then at room temperature (21 degrees) for 10 minutes before proceeding to the kit protocol. Please note that frozen blood samples are known to yield more degraded RNA compared to fresh blood samples.

Citations

Title	Identification of MicroRNAs and Transcript Targets in Camelina sativa by Deep Sequencing and Computational Methods
Citation	PLoS One 2015.
Authors	S Poudel, N Aryal, C Lu

Title	Role of TLR13 in innate immune recognition of group B streptococci
Citation	Infection and Immunity 2014.
Authors	G Signorino, N Mohammadi, F Patane, M Buscetta, M Venza, I Venza, G Maneusco, A Midiri, L Alexopoulou, G Teti, C Biondo, C Beninati

Title	Novel expression of microRNAs in serum samples of Iraqi breast cancer women
Citation	American Journal of BioMedicine 2014.
Authors	Z Saad, M Arif, N Yassen, H Jasim, M Jelawe, J Brown

Title	microRNA-181b Regulates ALX/FPR2 Expression and Proresolution Signaling in Human Macrophages
Citation	The Journal of Biological Chemistry 2014.
Authors	AM Pierdomenico, A Recchiuti, F Simiele, M Codagnone, VC Mari, G Davi, M Romano

Title	Expanding the annotation of zebrafish microRNAs based on small RNA sequencing
Citation	Gene 2014 2014.
Authors	T Desvinges, MJ Beam, P Batzel, J Sydes, JH Postlethwait

Title	AcvR1-mediated BMP signaling in second heart field is required for arterial pole development: Implications for myocardial differentiation and regional identity
Citation	Developmental Biology 2014.
Authors	PS Thomas, S Radjerkar, J Lane, Y Mishina, V Kaartinen

Title	Quantification of Circularing miRNAs in Plasma: Effect of Preanalytical and Analytical Parameters on Their Isolation and Stability
Citation	Journal of Molecular Diagnostics 2013.
Authors	IS Sourvinou, A Markou, ES Lianidou

Title	A Panel of four MicroRNAs accurately differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration
Citation	Clinical Cancer Reseach 2012.
Authors	Xavier Keutgen, Filippo Filicori, Michael Crowley, et al.

Title	Effective inhibition of infectious bursal disease virus replication by 1 recombinant avian adeno-associated virus-delivered microRNAs
Citation	JGV Papers in Press. Published March 4, 2009 2009.
Authors	Yongjuan Wang1, Huaichang Sun1*, Pengpeng Shen1, Xinyu Zhang1 and Xiaoli X

microRNA Purification Kit